Architect HBsAg Next Assay
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $47,031 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $47,031 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Design Validation Protocol for the Evaluation of Architect HBsAG Next Qualitative and Alinity HBsAG NEXT qualitative Confirmatory Assays | Abbott Laboratories | $29,531 | 0 |
| Evaluation of ARCHITECT HBsAg Next Qualitative and Alinity HBsAg Next Qualitative Confirmatory Assays | Abbott Laboratories | $17,500 | 0 |
Top Doctors Receiving Payments for Architect HBsAg Next Assay
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boca Raton, FL | $47,031 | 3 |
Manufacturing Companies
- Abbott Laboratories $47,031
Product Information
- Type Device
- Total Payments $47,031
- Total Doctors 0
- Transactions 3
About Architect HBsAg Next Assay
Architect HBsAg Next Assay is a device associated with $47,031 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $47,031 was paid across 3 transactions to 0 doctors.
The most common payment nature for Architect HBsAg Next Assay is "Unspecified" ($47,031, 100.0% of total).
Architect HBsAg Next Assay is associated with 2 research studies, including "Design Validation Protocol for the Evaluation of Architect HBsAG Next Qualitative and Alinity HBsAG NEXT qualitative Confirmatory Assays" ($29,531).